New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging

Frontiers in Pharmacology
Claudio de LuciaWalter J Koch

Abstract

Heart failure (HF) has become increasingly common within the elderly population, decreasing their survival and overall quality of life. In fact, despite the improvements in treatment, many elderly people suffer from cardiac dysfunction (HF, valvular diseases, arrhythmias or hypertension-induced cardiac hypertrophy) that are much more common in an older fragile heart. Since β-adrenergic receptor (β-AR) signaling is abnormal in failing as well as aged hearts, this pathway is an effective diagnostic and therapeutic target. Both HF and aging are characterized by activation/hyperactivity of various neurohormonal pathways, the most important of which is the sympathetic nervous system (SNS). SNS hyperactivity is initially a compensatory mechanism to stimulate contractility and maintain cardiac output. Unfortunately, this chronic stimulation becomes detrimental and causes decreased cardiac function as well as reduced inotropic reserve due to a decrease in cardiac β-ARs responsiveness. Therapies which (e.g., β-blockers and physical activity) restore β-ARs responsiveness can ameliorate cardiac performance and outcomes during HF, particularly in older patients. In this review, we will discuss physiological β-adrenergic signaling and its a...Continue Reading

References

Sep 1, 1991·Metabolism: Clinical and Experimental·G PaolissoF D'Onofrio
Jul 22, 1982·The New England Journal of Medicine·M R BristowE B Stinson
Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Jul 1, 1995·Journal of Cardiovascular Pharmacology·O E BroddeH Oelert
Oct 1, 1993·Journal of the American College of Cardiology·K K HoD Levy
Mar 1, 1993·The American Journal of Physiology·M BöhmE Erdmann
Jul 15, 1996·The Journal of Clinical Investigation·C GauthierH Le Marec
Feb 16, 1999·Archives of Internal Medicine·G S Pepper, R W Lee
May 20, 1999·Annual Review of Pharmacology and Toxicology·S R PostP A Insel
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·G W DornS B Liggett
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·S EngelhardtM J Lohse
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·D C WhiteW J Koch
May 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·V B HardingH A Rockman
Jul 18, 2001·The Journal of Biological Chemistry·X SongH Wang
Jul 28, 2001·European Journal of Clinical Investigation·J E DonckierJ L Balligand
Jan 24, 2002·Nature·Howard A RockmanRobert J Lefkowitz
Apr 17, 2002·Circulation·John S Floras
Oct 24, 2002·Journal of the American College of Cardiology·Kirsten LeineweberOtto Erich Brodde
Aug 9, 2003·Proceedings of the National Academy of Sciences of the United States of America·Satoshi OkumuraYoshihiro Ishikawa
Oct 18, 2003·Journal of the American College of Cardiology·Kirsten LeineweberOtto Erich Brodde
Nov 15, 2003·Circulation Research·Martin J LohseThomas Eschenhagen
Feb 14, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Atsushi MorimotoChe-Ping Cheng
Nov 25, 2004·The Nursing Clinics of North America·Scott D Mendzef, Jennifer R Slovinski
Dec 2, 2004·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Sabina De GeestHanspeter Brunner-La Rocca
May 12, 2005·The American Journal of Geriatric Cardiology·Michel G KhouriLyna El-Khoury Rumbarger
Aug 2, 2005·European Heart Journal·Guido IaccarinoWalter J Koch
Nov 18, 2005·Cardiovascular Research·Petronila PenelaFederico Mayor

❮ Previous
Next ❯

Citations

Aug 14, 2019·Heart Failure Reviews·Daniel Chikere AliLi Changxing
Oct 28, 2019·International Journal of Molecular Sciences·Vera PaarLukas J Motloch
Oct 16, 2019·Journal of Neurochemistry·Eugene Gonzalez-Lopez, Kent E Vrana
May 13, 2020·Cell Transplantation·Sherin Saheera, Prasanna Krishnamurthy
May 30, 2020·Pharmaceuticals·Rita PeixotoMiguel Oliveira
Aug 7, 2019·Toxicological Sciences : an Official Journal of the Society of Toxicology·Nicole T FericRoozbeh Aschar-Sobbi
Jul 14, 2020·Frontiers in Bioengineering and Biotechnology·Sarka JelinkovaVladimir Rotrekl
Aug 29, 2020·Cells·Karina FormosoJeanne Mialet-Perez
Sep 11, 2020·Cardiovascular Drugs and Therapy·Suman DalalKrishna Singh
Dec 13, 2018·Frontiers in Pharmacology·Supachoke MangmoolHitoshi Kurose
May 17, 2019·International Journal of Molecular Sciences·Shanna Hamilton, Dmitry Terentyev
Mar 29, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Melissa LieuWalter J Koch
Jun 20, 2020·Journal of Feline Medicine and Surgery·Keisuke SugimotoYoko Fujii
Aug 23, 2020·International Journal of Molecular Sciences·Hayyaf S AldossaryAndrew P Holmes
Mar 20, 2019·Basic Research in Cardiology·Lucas BacmeisterDiana Lindner
Dec 2, 2020·BMC Veterinary Research·Pinar LeventZeki Yilmaz
Jan 17, 2021·International Journal of Molecular Sciences·Min Young ParkIk Jin Yun
Jan 28, 2021·Proceedings of the National Academy of Sciences of the United States of America·Akito EguchiWalter J Koch
Feb 11, 2021·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Ali KamiarLina A Shehadeh
Nov 18, 2020·International Journal of Molecular Sciences·Miles A TannerLaurel A Grisanti
Jan 21, 2021·Cells·Marion LaudetteFrank Lezoualc'h
Feb 7, 2021·Journal of Molecular and Cellular Cardiology·Kimberly J McCabe, Padmini Rangamani
Dec 31, 2020·Entropy·Silvin P KnightRoman Romero-Ortuno
Jan 13, 2021·International Journal of Molecular Sciences·Gizem Kayki-Mutlu, Walter J Koch
Feb 17, 2021·Journal of Cardiovascular Translational Research·Shuang ZhengPeter H Backx
Aug 20, 2019·Biochimica Et Biophysica Acta. Molecular Cell Research·Senem SalcanSebastian Kötter

❮ Previous
Next ❯

Methods Mentioned

BETA
Transgenic

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.